{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:09:54Z","timestamp":1794262194136,"version":"4.9.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009011","name":"Ontario Centres of Excellence","doi-asserted-by":"publisher","award":["24467"],"award-info":[{"award-number":["24467"]}],"id":[{"id":"10.13039\/100009011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Canine lymphoma, the most common hematological cancer in dogs, shares many molecular and clinical characteristics with human Non-Hodgkin lymphoma (NHL). The standard treatment for canine lymphoma is \u201cCHOP\u201d multiagent chemotherapy protocol consisting of Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Vincristine (Oncovin\u2122), and Prednisone. Approximately 70\u201385% of patients treated with CHOP achieve clinical remission. However, duration of remission varies and the majority of dogs eventually relapse. To identify possible biomarkers for patients failing to achieve remission, we performed RNA-Seq analysis on 25 cases of canine lymphoma obtained prior the start of their CHOP therapy regime and assessed gene expression associated with patient progression free survival (PFS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Data description<\/jats:title><jats:p>The data consists of (1) raw RNA-Seq reads in 75\u00a0bp fastq format from fine needle aspirate samples of enlarged lymph nodes from canine patients with naturally occurring lymphoma; (2) Fragments Per Kilobase Million (FPKM) values for each sample; (3) raw transcript counts for each sample; (4) anonymized patient details including PFS; (5) heat map of gene expression and (6) Cox proportional hazard analysis showing significantly expressed genes. These data may be useful for comparative analysis of gene expression in human NHL and analysis of gene expression associated with disease outcome in canine lymphoma.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13104-022-06003-5","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:03:35Z","timestamp":1647943415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["RNA-Seq analysis of gene expression in 25 cases of canine lymphoma undergoing CHOP chemotherapy"],"prefix":"10.1186","volume":"15","author":[{"given":"Miles W.","family":"Mee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Bienzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-5562","authenticated-orcid":false,"given":"Brenda L.","family":"Coomber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"issue":"1","key":"6003_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hon.2017","volume":"31","author":"L Marconato","year":"2013","unstructured":"Marconato L, Gelain ME, Comazzi S. The dog as a possible animal model for human non-Hodgkin lymphoma: a review. Hematol Oncol. 2013;31(1):1\u20139.","journal-title":"Hematol Oncol"},{"issue":"20","key":"6003_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"3\u20134","key":"6003_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.vetimm.2014.02.016","volume":"159","author":"D Ito","year":"2014","unstructured":"Ito D, Frantz AM, Modiano JF. Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications. Vet Immunol Immunopathol. 2014;159(3\u20134):192\u2013201.","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"6003_CR4","first-page":"196","volume":"8","author":"K Sorenmo","year":"2010","unstructured":"Sorenmo K, Overley B, Krick E, Ferrara T, LaBlanc A, Shofer F. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases. Vet Comp Oncol. 2010;8(3):196\u2013208.","journal-title":"Vet Comp Oncol"},{"issue":"4","key":"6003_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235\u201342.","journal-title":"N Engl J Med"},{"issue":"4","key":"6003_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2460\/javma.238.4.501","volume":"238","author":"AB Flory","year":"2011","unstructured":"Flory AB, Rassnick KM, Erb HN, Garrett LD, Northrup NC, Selting KA, et al. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000\u20132007). J Am Vet Med Assoc. 2011;238(4):501\u20136.","journal-title":"J Am Vet Med Assoc"},{"issue":"16","key":"6003_CR7","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1158\/0008-5472.CAN-12-3546","volume":"73","author":"KL Richards","year":"2013","unstructured":"Richards KL, Motsinger-Reif AA, Chen HW, Fedoriw Y, Fan C, Nielsen DM, et al. Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL. Cancer Res. 2013;73(16):5029\u201339.","journal-title":"Cancer Res"},{"issue":"4","key":"6003_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1939-1676.2008.0143.x","volume":"22","author":"RB Rebhun","year":"2008","unstructured":"Rebhun RB, Lana SE, Ehrhart EJ, Charles JB, Thamm DH. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. J Vet Intern Med. 2008;22(4):989\u201395.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"6003_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1040638717743280","volume":"30","author":"OR Sierra Matiz","year":"2018","unstructured":"Sierra Matiz OR, Santilli J, Anai LA, Da Silva MCL, Sueiro FA, Sequeira JL, et al. Prognostic significance of Ki67 and its correlation with mitotic index in dogs with diffuse large B-cell lymphoma treated with 19-week CHOP-based protocol. J Vet Diagn Invest. 2018;30(2):263\u20137. https:\/\/doi.org\/10.1177\/1040638717743280.","journal-title":"J Vet Diagn Invest"},{"key":"6003_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.vetimm.2017.07.008","volume":"191","author":"N Deravi","year":"2017","unstructured":"Deravi N, Berke O, Woods JP, Bienzle D. Specific immunotypes of canine T cell lymphoma are associated with different outcomes. Vet Immunol Immunopathol. 2017;191:5\u201313.","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"6003_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1476-5829.2009.00201.x","volume":"8","author":"E Vezzali","year":"2010","unstructured":"Vezzali E, Parodi AL, Marcato PS, Bettini G. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO. Vet Comp Oncol. 2010;8(1):38\u201349.","journal-title":"Vet Comp Oncol"},{"key":"6003_CR12","doi-asserted-by":"crossref","unstructured":"Mee WM, Faulker S, Wood GA, Woods JP, Bienzle D, Coomber BL. Replication Data for RNA-Seq analysis of gene expression in 25 cases of canine lymphoma undergoing CHOP chemotherapy. NCBI Gene Expression Omnibus (GEO). 2021. https:\/\/identifiers.org\/geo:GSE130874","DOI":"10.1186\/s13104-022-06003-5"},{"key":"6003_CR13","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/. Accessed 16 Mar 2022"},{"issue":"D1","key":"6003_CR14","doi-asserted-by":"publisher","first-page":"D710","DOI":"10.1093\/nar\/gkv1157","volume":"44","author":"A Yates","year":"2016","unstructured":"Yates A, Akanni W, Amode MR, Barrell D, Billis K, Carvalho-Silva D, et al. Ensembl 2016. Nucleic Acids Res. 2016;44(D1):D710\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"6003_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357\u201360.","journal-title":"Nat Methods"},{"issue":"3","key":"6003_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290\u20135.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"6003_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nbt.3172","volume":"33","author":"AC Frazee","year":"2015","unstructured":"Frazee AC, Pertea G, Jaffe AE, Langmead B, Salzberg SL, Leek JT. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat Biotechnol. 2015;33(3):243\u20136.","journal-title":"Nat Biotechnol"},{"key":"6003_CR18","doi-asserted-by":"publisher","unstructured":"Mee WM, Faulker S, Wood GA, Woods JP, Bienzle D, Coomber BL. Replication Data for RNA-Seq analysis of gene expression in 25 cases of canine lymphoma undergoing CHOP chemotherapy. Harvard Dataverse. https:\/\/doi.org\/10.7910\/DVN\/PGL3BO. Accessed 16 Mar 2022","DOI":"10.7910\/DVN\/PGL3BO"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-022-06003-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T18:54:56Z","timestamp":1675018496000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-022-06003-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6003"],"URL":"https:\/\/doi.org\/10.1186\/s13104-022-06003-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Canadian Council on Animal Care (CCAC) Guidelines, as approved and supervised by the University of Guelph Animal Care Committee. Informed consent for sample collection for this study was obtained from all clients prior to enrollment of their dogs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}